• Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Average Rating of "Moderate Buy" by Brokerages

    Source: Buzz FX / 05 Oct 2024 02:06:12   America/New_York


    Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Average Rating of "Moderate Buy" by Brokerages Written by MarketBeat October 5, 2024 Share Link copied to clipboard. Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN - Get Free Report ) has e
    Read more...
Share on,